Skip to content

Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513918-35-00
Acronym
74856665AML1001
Enrollment
1
Registered
2024-07-26
Start date
2020-12-22
Completion date
2025-08-25
Last updated
2024-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia or Myelodysplastic syndrome

Interventions

None listed

Sponsors

Janssen Cilag International
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026